CAERULEUS GENOMICS LTD
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
What does Caeruleus Genomics Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
CAERULEUS GENOMICS LTD is an active private limited company (company number 14481675) incorporated on 14 November 2022, registered in Oxford. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 30 November 2025, showing net assets of £922k and cash of £595k, with 13 employees on average. Net assets rose 1285% on the prior period (−£78k). Across the last 3 periods on record the net-asset trend is volatile.
By net assets it sits in the top quarter of 152 comparable companies in Oxford (median £10k, upper quartile £474k).
Ownership and control
No active person with significant control is registered.
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 14 November 20223 yrs ago
- Next accounts due
- 30 August 2027in 311 days
- Confirmation statement due
- 28 November 2026in 36 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- SmallCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 November 2025 | £922k | £595k | — | £32k | — | — | 13 |
| 30 November 2024 | −£78k | £2.05m | — | £2.17m | — | — | 9 |
| 30 November 2023 | £356k | £305k | — | £23k | — | — | 5 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £921,559 at 30 November 2025
- Net assets up 10% or more on the prior period+1285.4% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 27.53
- Cash at bank of £50,000 or moreCash £594,786
- Three or more accounting periods on record3 periods on record
- Incorporated two to five years agoIncorporated 14 November 2022
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 311 days
- Confirmation statement duein 36 days
- Accounts period endNet assets £922k · small accounts
- Accounts period endNet liabilities £78k · small accounts
- Accounts period endNet assets £356k · small accounts
- Incorporated
Similar companies in Oxford
- IUVANTIUM LIMITEDThame · inc. Dec 2022
- ISOGENIX LIMITEDOxford · inc. Dec 2022
- FERMENTATION TECHNOLOGIES LTDOxford · inc. Sept 2022
- YELLOWSTONE BIOSCIENCES LIMITEDOxford · inc. Jan 2023
- ALVEOGENE LIMITEDOxford · inc. Sept 2022
- RIVER THERAPEUTICS LTDOxford · inc. Aug 2022
All companies incorporated on 14 November 2022 · in Nov 2022.
Reminders for CAERULEUS GENOMICS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.